You are here: All Products  > Sichuan Haisco Invests $6 Million in eXithera, Gains China Rights to Novel Anti-Coagulant

Sichuan Haisco Invests $6 Million in eXithera, Gains China Rights to Novel Anti-Coagulant

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products